AASLD is actively monitoring events related to the COVID-19 pandemic and will provide timely information and resources to support health care providers in hepatology, liver transplantation and gastroenterology as well as their patients and caregivers. This resource page will be updated regularly as more data become available to the AASLD Leadership.

For the Clinician

AASLD's "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic"

This document provides data on what is known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a basic template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and health care providers. This document will continue to evolve and be reviewed by the authors and AASLD Governing Board, and be revised and updated as needed in response to the COVID-19 pandemic.

NEW! Read AASLD's Clinical Insights. [Updated: May 14, 2020 | What's New in the May 14 document]

NEW! Read the Spanish version of AASLD's Clinical Insights. [Updated: May 20, 2020. Translation of the May 14, 2020 document.]

NEW! Read the Portuguese version of AASLD's Clinical Insights. [Updated: May 20, 2020. Translation of the May 14, 2020 document.]

Upcoming Webinars

Thursday, May 28
AASLD-ALEH webinar: COVID-19 and the Liver in the Americas"

On Thursday, May 28, AASLD and ALEH will host a webinar dedicated to the impact of COVID-19 on liver disease and transplantation in the Americas, and the latest on COVID-19 management strategies related to the care of patients with chronic liver disease and pre- and post-transplantation. Faculty will also share strategies surrounding re-entry and the re-opening of clinics and hospitals for patients with liver disease.

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, May 26, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.

Thursday, May 28
EGHS-AASLD webinar – "COVID-19 Pandemic: Implications in Liver Disease & Transplantation"
Learn more and register.

Thursday, June 4
AASLD webinar – "COVID-19 and the Liver: Telemedicine during the COVID-19 Pandemic and Beyond"
Learn more and register.

 

For the Clinician

  • Joint Society Messages

Joint Society Message: Use of Personal Protective Equipment in GI Endoscopy

Read the joint societies' statement.

Joint Society Message: Gastroenterology Professional Society Guidance on Endoscopic Procedures during the COVID-19 Pandemic

Read the joint societies' statement.

Joint GI Society Message: COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers

Read the joint GI societies' statement.

AGA issues formal recommendations for PPE during gastrointestinal procedures

Read AGA's recommendations.

"COVID-19 and the Liver" Webinar Series Archive

  • May 14, 2020 Webinar
  • April 30, 2020 Webinar
  • April 16, 2020 Webinar
  • April 7, 2020 Webinar
  • March 26, 2020 Webinar

Webinar: "COVID-19 and the Liver – Reentry & Return to a Pre-Pandemic State"

On May 14, AASLD hosted a webinar dedicated to ongoing discoveries and discussions about COVID-19 and how it impacts the care of liver patients. Participants will be able to:

  • Understand the challenges institutions face in resuming pre-pandemic operations..
  • Realize the ways to begin a safe outpatient reentry process for patients with liver disease.
  • Describe how transplant centers are carefully planning for reentry.

NEW! Watch the pre-recorded webinar.

NEW! Download the slide presentation.

AASLD's Clinical and Public Policy Positions

  • The Administration
  • Congress
  • Centers for Disease Control and Prevention
  • Centers for Medicare & Medicaid Services

AASLD joins 200 Organizations in Letter to Administration regarding PPE and Ventilators

Read the joint societies' letter to the Administration.

What You Can Do

  • Actions You Can Take

AASLD seeks COVID-19 Manuscript Submissions

Read the letter from AASLD journal Editors-in-Chief David Cohen, Paul Martin and Gyongyi Szabo.

COVID-19 Discussion Community in Engage

AASLD members have an outlet to share and discuss COVID-19 and how it's affecting care delivery to patients with liver disease.

Join the conversation.

Write your Congressional Representatives and Senators

Join us and make your voice heard: Use our online advocacy tool to send an email to your legislators about how COVID-19 is impacting you and what needs to be done to protect you, your colleagues and your patients during this urgent time.

 

Journal References for COVID-19

  • AASLD Journal Articles
  • Resources from Other Publishers

Other Resources

  • American Medical Association
  • Centers for Disease Control and Prevention
  • Centers for Medicare and Medicaid Services
  • Food & Drug Administration
  • Health & Human Services
  • Health Care Resiliency Taskforce
  • National Institutes of Health
  • SECURE-Cirrhosis
  • AABB
  • AASLD News